Dr. Edmision - November 14th


Published on

Published in: Health & Medicine
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Dr. Edmision - November 14th

  1. 1. CornealCrosslinking Dr. David Edmison 14th, 2012
  2. 2. Corneal Crosslinking• CXL proposed by Dr. Theo Seiler (Dresden) in 2000.• Combination of riboflavin & UVA (3mw/cm2 at 370nm) to strengthen the cornea.• Involves photopolymerization of stromal fibers which increases the rigidity of corneal collagen and its resistance to deformation.• After UVA exposition the riboflavin is excited into a triplet state and generates singlet oxygen. These induce the formation of new covalent bonds between the amino acids of neighbouring collagen fibres and results in a stiffening of the cornea.
  3. 3. Corneal Crosslinking
  4. 4. Corneal CrosslinkingKeratoconus: less crosslinking After CXL: more crosslinking Creates chemical bonds between collagen fibers
  5. 5. Corneal Crosslinking
  6. 6. Keratectasia Keratoconus Post LASIK ectasia Pellucid Marginal Degenaration Therapeutic treatment – variable Rx and K’s during post-op period (1-6 mths)
  7. 7. KeratectasiaKeratoconus 1/2000: usually in adolescence, peaks at age 20-35 Thinning of corneal stroma Clinically:  irregular scissor reflex on retinoscopy  Vertical striae (Vogt)  Fleischer’s ring (hemosiderin)  Stromal edema with breaks in Descemet’s → hydrops  Munson’s sign Path: defects in Bowman’s Etiology: genetic, atopic disease, asthma, exzema, eye rubbing 10-25% require transplant or lamellar Sx.
  8. 8. Corneal Crosslinking  Intrastormal ring segments + CXL Intrastromal ring segments + CXL
  9. 9. KeratectasiaPost LASIK ectasia Variable degrees of corneal thinning in stromal bed and flap Macrostriae in stromal bed Steepening of central cornea +/- iron ring around steepening. Thinning of stromal collagen lamellae Occasional scarring at flap-stromal bed interface
  10. 10. KeratectasiaPellucid Marginal Degenaration Thinning in periphery of cornea Usually high against the rule astigmatism.
  11. 11. Corneal CrosslinkingOther indications for CXL Recalcitrant corneal ulcers  Reduces pathogen load  Increases resistance to collagenases Reducing corneal edema in Bullous keratopathy & Fuch’s Reducing hyperopic shift following RK Prophylactic for all patients treated with PRK with high myopia or Forme Fruste K
  12. 12. Corneal Crosslinking Bacteria can be eliminated using the combination of UV-A and riboflavin
  13. 13. Corneal Crosslinking85-year-old woman with anadvanced infectious ulcer,including presence of hypopyon.
  14. 14. Corneal CrosslinkingAdvantages Stabilizes (slows or stops) progression of keratectasia. Some flattening of the cornea Studies show results last at least 3 years Synergistic effect with PRK as seen in Athens protocol. Helps treat resistant bacterial ulcers.
  15. 15. Corneal CrosslinkingDisadvantages No long term data Stabilizing effect shown but minimal improvement in VA for patients. Of 200 reported studies only 10 are prospective, randomized and controlled. No titration of dose to degree of keratectasia. Sterile infiltrates and stromal scars reported. Rare corneal melt and damage to endothelium. Estimated that CXL has same stiffening impact on cornea as 30 years of aging.
  16. 16. Corneal Crosslinking
  17. 17. Corneal Crosslinking Riboflavin (0.1%) and UVA (365nm) 3-45 mW/cm2 Corneal epithelium off or on Treatment for corneal disorders & infections Adjunct therapy for LVCIndications: Keratoconus Ectasia (post LVC) Resistant bacterial infections
  18. 18. Corneal Crosslinking Crosslinked corneaUsed for years in dentistryto harden polymers. Normal cornea
  19. 19. Corneal Crosslinking Athens Protocol  Combined partial PRK and CXL  Not a refractive procedure
  20. 20. Corneal CrosslinkingProvide extra corneal strengthening preventing ectasia
  21. 21. Focus Eye CentreThank you!